IRMD
IRADIMED CORP
Key Financials
Gross Profit
$64.3M
↑ 14.2%
Total Assets
$108.8M
↑ 10.6%
Total Liabilities
$14.2M
↑ 23.0%
Operating Income
$26.1M
↑ 19.0%
Net Income
$22.5M
↑ 16.9%
Revenue
$83.8M
↑ 14.4%
EPS (Diluted)
$1.75
↑ 16.7%
Operating Cash Flow
$24.9M
↓ 2.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 9/25/2026 | View on SEC |
| 4 | 9/8/2026 | View on SEC |
| 144 | 9/3/2026 | View on SEC |
| 8-K/A | 8/18/2026 | View on SEC |
| 10-Q | 7/31/2026 | View on SEC |
| 8-K | 7/31/2026 | View on SEC |
| SCHEDULE 13G | 7/28/2026 | View on SEC |
| 8-K | 6/24/2026 | View on SEC |
| 4 | 6/23/2026 | View on SEC |
| 4 | 6/4/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | IRMD |
| Company Name | IRADIMED CORP |
| CIK | 1325618 |
| Sector | Surgical & Medical Instruments & Apparatus |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 4076778022 |